E-drug: Generic substitution (cont'd)
---------------------------------------------------------------------
Dear friends:
I'm afraid the message was not clear enough. Of course the main
target of our policy in Colombia is to reduce costs. And we are quite
satisfied about the results. Our policy defines the "generic" choice. In
other words the substitution option. No interchangeability. What is the
difference? Usually when one talks about interchangeability, one talks
about doing bio-bio tests as a general mandatory requirement.
Substitution is only being able to choose between alternatives, and
bio-bio tests are an exceptional requirement. Maybe this situation only
exists in Latin America?
In narrow therapeutic window drugs you can select options, and we
need a lot of options. Our recommendation is not to switch from one
to another manufacturer, if possible. This is recommended for both
generic and brandname drugs. And if necessary, only with carefully
follow up.
Francisco A. Rossi. B.
Advisor
Ministerio de Protecci�n Social, Colombia
Carrera 13 No 32-76
Tel 57-1-3365066 ext 2229
fax 57-1-3360165
e-mail: francisco_rossi@hotmail.com
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug